Home » Authors » Jim Shrine

Articles by Jim Shrine

Marcadia Raises $15M In First Round For Metabolic Programs

May 16, 2007

ProCertus Completes Series A Financing For Cancer Programs

May 11, 2007

ProCertus Completes Series A Financing For Cancer Programs

May 11, 2007

Avid Raises $26M In Series C For Molecular imaging Agents

May 10, 2007

Avid Raises $26M In Series C For Molecular imaging Agents

May 10, 2007

Progen Raising $61M To Fund Phase III Cancer Trials Of PI-88

May 4, 2007

Progen Raising $61M To Fund Phase III Cancer Trials Of PI-88

May 4, 2007

Array Raises $91M Publicly For Cancer, Inflammation Programs

May 3, 2007

Array BioPharma Inc. raised $91 million in a public offering of stock, money that will be used to fund development of its broad, early stage pipeline of small-molecule drug candidates for cancer and inflammatory diseases. (BioWorld Today)

Array Raises $91M Publicly For Cancer, Inflammation Programs

May 3, 2007

Array BioPharma Inc. raised $91 million in a public offering of stock, money that will be used to fund development of its broad, early stage pipeline of small-molecule drug candidates for cancer and inflammatory diseases. (BioWorld Today)

Italian Firm Eurand Files For IPO On Nasdaq Of Up To $153M

May 2, 2007

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 18, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...